FDA Commissioner Martin Makary recently highlighted the role of CGMs in preventing chronic conditions, questioning why they are only available on prescription. Could there be any benefit to the diabetes community of a policy change?
New medtech startup, Luna Health, based in the US, have raised $23.6 million to advance a patch pump designed specifically for overnight use only.
FDA approval of Simplera Sync sensor paired with MiniMed™ 780G insulin pump.
Latest news from key diabetes conference covering the latest in medtech, treatments, research and 'cures'.
Dexcom's financial filings reveal a warning letter from the FDA regarding processing in 2 of its manufacturing plants.
Abbott announce that FreeStyle Libre 3 sensors will be phased out in the UK by the end of 2025 and users will need to move to FreeStyle Libre 3 Plus.
A new CGM launches this February in the UK.
News that Abbott and Dexcom have agreed not to sue each other for patents relating to their CGM tech for another 10 years.
Sana Biotechnology announce a significant step in the use of islet cells for T1D treatment that could pave the way to a T1D 'cure'!
